Vereinbaren Sie ein Beratungsgespräch über Stammzellen
Mehr erfahren
Kontaktieren Sie uns noch heute!
Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.
Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
Nr.
Quelle
Quellentyp
Diagnose
Medizinbereich
Anwendungsjahr
Therapie
Land
Alter des Empfängers
2401
Apheresis
Autologous
Multiple Myeloma
Hematology
2023
Standard Therapy
Germany
42
2402
Apheresis
Autologous
Multiple Myeloma
Hematology
2023
Standard Therapy
Germany
62
2403
Apheresis
Autologous
Multiple Myeloma
Hematology
2023
Standard Therapy
Germany
50
2404
Apheresis
Autologous
Multiple Myeloma
Hematology
2023
Standard Therapy
Germany
59
2405
Apheresis
Autologous
Multiple Myeloma
Hematology
2023
Standard Therapy
Germany
56
2406
Apheresis
Autologous
Multiple Myeloma
Hematology
2023
Standard Therapy
Germany
64
2407
Apheresis
Autologous
Multiple Myeloma
Hematology
2023
Standard Therapy
Germany
59
2408
Apheresis
Allogeneic
Mycosis Fungoides
Hematology
2023
Standard Therapy
Poland
62
2409
Apheresis
Allogeneic
Myelodysplastic Disorders
Hematology
2023
Standard Therapy
Poland
57
2410
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
71
2411
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
64
2412
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
67
2413
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
56
2414
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
41
2415
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
70
2416
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
57
2417
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
70
2418
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
47
2419
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
29
2420
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
66
2421
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
68
2422
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
40
2423
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
56
2424
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
69
2425
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
59
2426
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
56
2427
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
68
2428
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
66
2429
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
63
2430
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
64
2431
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
64
2432
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
63
2433
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
65
2434
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
68
2435
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
44
2436
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
66
2437
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
48
2438
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
45
2439
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
67
2440
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
69
2441
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
72
2442
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
53
2443
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
71
2444
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
66
2445
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
57
2446
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
74
2447
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2023
Standard Therapy
Poland
72
2448
Apheresis
Allogeneic
Myelodysplastic Syndrome Lb High Risk
Hematology
2023
Standard Therapy
Poland
58
2449
Apheresis
Allogeneic
Myelodysplastic Syndrome With Multilineage Dysplasia
Hematology
2023
Standard Therapy
Poland
68
2450
Apheresis
Allogeneic
Myelodysplastic Syndrome/Acute Myelogenous Leukemia
Hematology
2023
Standard Therapy
Poland
42
2451
Apheresis
Allogeneic
Myelodysplastic Syndrome-Eb1
Hematology
2023
Standard Therapy
Poland
48
2452
Apheresis
Allogeneic
Myelodysplastic Syndromes (MDS)
Hematology
2023
Standard Therapy
Poland
73
2453
Apheresis
Allogeneic
Myelodysplastic Syndromes (MDS)
Hematology
2023
Standard Therapy
Poland
76
2454
Apheresis
Allogeneic
Myelodysplastic Syndromes (MDS)
Hematology
2023
Standard Therapy
Poland
70
2455
Apheresis
Allogeneic
Myelodysplastic Syndromes (MDS)
Hematology
2023
Standard Therapy
Poland
5
2456
Apheresis
Allogeneic
Myelofibrosis
Hematology
2023
Standard Therapy
Poland
65
2457
Apheresis
Allogeneic
Myelofibrosis
Hematology
2023
Standard Therapy
Poland
56
2458
Apheresis
Allogeneic
Myelofibrosis
Hematology
2023
Standard Therapy
Poland
70
2459
Apheresis
Allogeneic
Myelofibrosis
Hematology
2023
Standard Therapy
Poland
69
2460
Apheresis
Allogeneic
Myelofibrosis
Hematology
2023
Standard Therapy
Poland
61
2461
Apheresis
Allogeneic
Myelofibrosis
Hematology
2023
Standard Therapy
Poland
70
2462
Apheresis
Allogeneic
Myelofibrosis
Hematology
2023
Standard Therapy
Poland
68
2463
Apheresis
Allogeneic
Myelofibrosis Myeloid Metaplasia
Hematology
2023
Standard Therapy
Poland
50
2464
Apheresis
Allogeneic
Myelofibrosis Myeloid Metaplasia
Hematology
2023
Standard Therapy
Poland
54
2465
Apheresis
Allogeneic
Myelofibrosis Myeloid Metaplasia
Hematology
2023
Standard Therapy
Poland
60
2466
Apheresis
Allogeneic
Myeloma Multiplex
Hematology
2023
Standard Therapy
Poland
63
2467
Apheresis
Autologous
No Data
Hematology
2023
Standard Therapy
Germany
69
2468
Apheresis
Autologous
No Data
Hematology
2023
Standard Therapy
Germany
53
2469
Apheresis
Allogeneic
No Data
Hematology
2023
Standard Therapy
Poland
50
2470
Apheresis
Allogeneic
No Data
Hematology
2023
Standard Therapy
Poland
23
2471
Apheresis
Allogeneic
No Data
Hematology
2023
Standard Therapy
Poland
39
2472
Apheresis
Allogeneic
No Data
Hematology
2023
Standard Therapy
Poland
2
2473
Apheresis
Allogeneic
No Data
Hematology
2023
Standard Therapy
Poland
52
2474
Apheresis
Allogeneic
No Data
Hematology
2023
Standard Therapy
Poland
61
2475
Apheresis
Autologous
No Data
Hematology
2023
Standard Therapy
Germany
60
2476
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
71
2477
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
44
2478
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
72
2479
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
66
2480
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
33
2481
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
42
2482
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
63
2483
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
19
2484
Apheresis
Allogeneic
Non-Hodgkin Lymphoma
Hematology
2023
Standard Therapy
Poland
54
2485
Apheresis
Autologous
Nonseminoma, Relapse
Hematology
2023
Standard Therapy
Germany
48
2486
Apheresis
Allogeneic
Orofacial Myofunctional Disorders (OMDS), Primary Myelofibrosis (PMF)
Hematology
2023
Standard Therapy
Poland
69
2487
Apheresis
Allogeneic
Osteomyelofibrosis
Hematology
2023
Standard Therapy
Poland
60
2488
Apheresis
Allogeneic
Other Immune System
Hematology
2023
Standard Therapy
Poland
71
2489
Apheresis
Allogeneic
Other Malignancy
Hematology
2023
Standard Therapy
Poland
49
2490
Apheresis
Allogeneic
Other Myelofibrosis
Hematology
2023
Standard Therapy
Poland
56
2491
Apheresis
Allogeneic
Other Non-Malignant Disease
Hematology
2023
Standard Therapy
Poland
70
2492
Apheresis
Allogeneic
Paroxysmal Nocturnal Hemoglobinuria (Pnh)
Hematology
2023
Standard Therapy
Poland
36
2493
Apheresis
Allogeneic
Peripheral T-Cell Lymphoma
Hematology
2023
Standard Therapy
Poland
47
2494
Apheresis
Autologous
Plasma Cell Leukemia
Hematology
2023
Standard Therapy
Germany
70
2495
Apheresis
Autologous
Plasma Cell Leukemia
Hematology
2023
Standard Therapy
Germany
56
2496
Apheresis
Autologous
Plasmacytoma
Hematology
2023
Standard Therapy
Germany
63
2497
Apheresis
Allogeneic
Post Therapeutic Myelodysplastic Syndrome /Acute Myelogenous Leukemia After Chronic Lymphocytic Leukemia
Hematology
2023
Standard Therapy
Poland
60
2498
Apheresis
Allogeneic
Post–Polycythemia Vera Myelofibrosis
Hematology
2023
Standard Therapy
Poland
38
2499
Apheresis
Allogeneic
Pra B-Cell Acute Lymphoblastic Leukemia
Hematology
2023
Standard Therapy
Poland
20
2500
Apheresis
Allogeneic
Pre-B-Acute Lymphoblastic Leukemia
Hematology
2023
Standard Therapy
Poland
41